Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions

Tetsuo Ikeda, Naoyuki Ueda, Yusuke Yonemura, Kohjiro Mashino, Akira Kabashima, Kiminori Watanabe, Kyuzo Fujii, Hideya Tashiro, Hisanobu Sakata

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose. To evaluate the technical feasibility and safety of overtube-guided covered metallic stent placement as palliative treatment for patients with inoperable malignant gastric outlet obstructions. Methods. To relieve the symptoms of severe nausea and recurrent vomiting in five patients with inoperable gastric cancer, we used an overtube (Long overtube; Sumitomo Bakelite, Tokyo, Japan) to place largediameter, self-expandable, covered esophageal Ultraflex stents (inner diameter 22-28 mm, length 10 or 12 cm; Boston Scientific, Watertown, MA, USA). Success was defined both technically and clinically. Results. The stent placement was technically successful in all patients and resulted in improvement of symptoms in all five patients, four of whom were thereafter able to ingest solid food. The remaining patient, a 94-year-old man, was unable to ingest food because of dysmasesis. During the mean follow-up of 17 weeks, there was no stent reocclusion and no life-threatening complications developed. Conclusions. The placement of a large diameter, self-expandable, covered esophageal stent using an overtube appears to be effective for the palliative treatment of malignant gastric outlet obstruction.

Original languageEnglish
Pages (from-to)637-642
Number of pages6
JournalSurgery today
Volume41
Issue number5
DOIs
Publication statusPublished - May 1 2011

Fingerprint

Stents
Gastric Outlet Obstruction
Palliative Care
Food
Tokyo
Nausea
Stomach Neoplasms
Vomiting
Japan
Self Expandable Metallic Stents
Safety

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Ikeda, T., Ueda, N., Yonemura, Y., Mashino, K., Kabashima, A., Watanabe, K., ... Sakata, H. (2011). Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions. Surgery today, 41(5), 637-642. https://doi.org/10.1007/s00595-009-4332-y

Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions. / Ikeda, Tetsuo; Ueda, Naoyuki; Yonemura, Yusuke; Mashino, Kohjiro; Kabashima, Akira; Watanabe, Kiminori; Fujii, Kyuzo; Tashiro, Hideya; Sakata, Hisanobu.

In: Surgery today, Vol. 41, No. 5, 01.05.2011, p. 637-642.

Research output: Contribution to journalArticle

Ikeda, T, Ueda, N, Yonemura, Y, Mashino, K, Kabashima, A, Watanabe, K, Fujii, K, Tashiro, H & Sakata, H 2011, 'Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions', Surgery today, vol. 41, no. 5, pp. 637-642. https://doi.org/10.1007/s00595-009-4332-y
Ikeda, Tetsuo ; Ueda, Naoyuki ; Yonemura, Yusuke ; Mashino, Kohjiro ; Kabashima, Akira ; Watanabe, Kiminori ; Fujii, Kyuzo ; Tashiro, Hideya ; Sakata, Hisanobu. / Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions. In: Surgery today. 2011 ; Vol. 41, No. 5. pp. 637-642.
@article{0cf7494656be4d398a5438b37dcf8704,
title = "Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions",
abstract = "Purpose. To evaluate the technical feasibility and safety of overtube-guided covered metallic stent placement as palliative treatment for patients with inoperable malignant gastric outlet obstructions. Methods. To relieve the symptoms of severe nausea and recurrent vomiting in five patients with inoperable gastric cancer, we used an overtube (Long overtube; Sumitomo Bakelite, Tokyo, Japan) to place largediameter, self-expandable, covered esophageal Ultraflex stents (inner diameter 22-28 mm, length 10 or 12 cm; Boston Scientific, Watertown, MA, USA). Success was defined both technically and clinically. Results. The stent placement was technically successful in all patients and resulted in improvement of symptoms in all five patients, four of whom were thereafter able to ingest solid food. The remaining patient, a 94-year-old man, was unable to ingest food because of dysmasesis. During the mean follow-up of 17 weeks, there was no stent reocclusion and no life-threatening complications developed. Conclusions. The placement of a large diameter, self-expandable, covered esophageal stent using an overtube appears to be effective for the palliative treatment of malignant gastric outlet obstruction.",
author = "Tetsuo Ikeda and Naoyuki Ueda and Yusuke Yonemura and Kohjiro Mashino and Akira Kabashima and Kiminori Watanabe and Kyuzo Fujii and Hideya Tashiro and Hisanobu Sakata",
year = "2011",
month = "5",
day = "1",
doi = "10.1007/s00595-009-4332-y",
language = "English",
volume = "41",
pages = "637--642",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions

AU - Ikeda, Tetsuo

AU - Ueda, Naoyuki

AU - Yonemura, Yusuke

AU - Mashino, Kohjiro

AU - Kabashima, Akira

AU - Watanabe, Kiminori

AU - Fujii, Kyuzo

AU - Tashiro, Hideya

AU - Sakata, Hisanobu

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Purpose. To evaluate the technical feasibility and safety of overtube-guided covered metallic stent placement as palliative treatment for patients with inoperable malignant gastric outlet obstructions. Methods. To relieve the symptoms of severe nausea and recurrent vomiting in five patients with inoperable gastric cancer, we used an overtube (Long overtube; Sumitomo Bakelite, Tokyo, Japan) to place largediameter, self-expandable, covered esophageal Ultraflex stents (inner diameter 22-28 mm, length 10 or 12 cm; Boston Scientific, Watertown, MA, USA). Success was defined both technically and clinically. Results. The stent placement was technically successful in all patients and resulted in improvement of symptoms in all five patients, four of whom were thereafter able to ingest solid food. The remaining patient, a 94-year-old man, was unable to ingest food because of dysmasesis. During the mean follow-up of 17 weeks, there was no stent reocclusion and no life-threatening complications developed. Conclusions. The placement of a large diameter, self-expandable, covered esophageal stent using an overtube appears to be effective for the palliative treatment of malignant gastric outlet obstruction.

AB - Purpose. To evaluate the technical feasibility and safety of overtube-guided covered metallic stent placement as palliative treatment for patients with inoperable malignant gastric outlet obstructions. Methods. To relieve the symptoms of severe nausea and recurrent vomiting in five patients with inoperable gastric cancer, we used an overtube (Long overtube; Sumitomo Bakelite, Tokyo, Japan) to place largediameter, self-expandable, covered esophageal Ultraflex stents (inner diameter 22-28 mm, length 10 or 12 cm; Boston Scientific, Watertown, MA, USA). Success was defined both technically and clinically. Results. The stent placement was technically successful in all patients and resulted in improvement of symptoms in all five patients, four of whom were thereafter able to ingest solid food. The remaining patient, a 94-year-old man, was unable to ingest food because of dysmasesis. During the mean follow-up of 17 weeks, there was no stent reocclusion and no life-threatening complications developed. Conclusions. The placement of a large diameter, self-expandable, covered esophageal stent using an overtube appears to be effective for the palliative treatment of malignant gastric outlet obstruction.

UR - http://www.scopus.com/inward/record.url?scp=79956226374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956226374&partnerID=8YFLogxK

U2 - 10.1007/s00595-009-4332-y

DO - 10.1007/s00595-009-4332-y

M3 - Article

VL - 41

SP - 637

EP - 642

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 5

ER -